---
title: "4886.JP (4886.JP) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/4886.JP/news.md"
symbol: "4886.JP"
name: "4886.JP"
parent: "https://longbridge.com/en/quote/4886.JP.md"
datetime: "2026-05-21T23:23:26.261Z"
locales:
  - [en](https://longbridge.com/en/quote/4886.JP/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/4886.JP/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/4886.JP/news.md)
---

# 4886.JP (4886.JP) — Related News

### [Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference](https://longbridge.com/en/news/277860992.md)
*2026-03-05T01:43:12.000Z*
> AnnJi Pharmaceutical Co., Ltd. participated in the 2026 KDA Conference, presenting advancements in AJ201, a potential fi

### [Teijin and Aska Pharmaceutical to co-develop gynaecological drugs](https://longbridge.com/en/news/276121581.md)
*2026-02-17T10:17:42.000Z*
> Teijin Pharma has entered a joint research agreement with Aska Pharmaceutical to co-develop small-molecule drug candidat

### [Estimating The Fair Value Of ASKA Pharmaceutical Holdings Co.,Ltd. (TSE:4886)](https://longbridge.com/en/news/274360566.md)
*2026-01-30T21:53:08.000Z*
> Using the 2 Stage Free Cash Flow to Equity model, ASKA Pharmaceutical Holdings Co., Ltd. (TSE:4886) has a fair value est